These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 9568082)

  • 1. Clinicopathologic differences between gastric remnant cancer and primary cancer in the upper third of the stomach.
    Imada T; Rino Y; Takahashi M; Shiozawa M; Hatori S; Noguchi Y; Amano T; Kobayashi O; Sairenji M; Motohashi H
    Anticancer Res; 1998; 18(1A):231-5. PubMed ID: 9568082
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinicopathologic differences between early gastric remnant cancer and early primary gastric cancer in the upper third of the stomach.
    Imada T; Rino Y; Hatori S; Shiozawa M; Takahashi M; Amano T; Kondo J; Kobayashi O; Sairenji M; Motohashi H
    Hepatogastroenterology; 2000; 47(34):1186-8. PubMed ID: 11020911
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gastric remnant cancer compared with primary proximal gastric cancer.
    Inomata M; Shiraishi N; Adachi Y; Yasuda K; Aramaki M; Kitano S
    Hepatogastroenterology; 2003; 50(50):587-91. PubMed ID: 12749279
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The outcome of patients with remnant primary gastric cancer compared with those having upper one-third gastric cancer.
    An JY; Choi MG; Noh JH; Sohn TS; Kim S
    Am J Surg; 2007 Aug; 194(2):143-7. PubMed ID: 17618792
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Surgical outcomes for early gastric cancer in the upper third of the stomach.
    Kunisaki C; Akiyama H; Nomura M; Matsuda G; Otsuka Y; Ono H; Shimada H
    J Am Coll Surg; 2005 Jan; 200(1):15-9. PubMed ID: 15631915
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Surgical treatment for advanced carcinoma of the gastric remnant.
    Isozaki H; Tanaka N; Fujii K; Nomura E; Tanigawa N
    Hepatogastroenterology; 1998; 45(23):1896-900. PubMed ID: 9840172
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Is gastric remnant cancer clinically different from primary gastric cancer?
    Lo SS; Wu CW; Hsieh MC; Lui WY
    Hepatogastroenterology; 1997; 44(13):299-301. PubMed ID: 9058163
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lymph node dissection in surgical treatment for remnant stomach cancer.
    Kunisaki C; Shimada H; Nomura M; Hosaka N; Akiyama H; Ookubo K; Moriwaki Y; Yamaoka H
    Hepatogastroenterology; 2002; 49(44):580-4. PubMed ID: 11995502
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relations of proliferative activities of gastric carcinoma cells to lymphatic involvement, venous invasion and prognosis.
    Wu YF; Xu HM; Chen JQ
    Chin Med J (Engl); 2004 Oct; 117(10):1530-5. PubMed ID: 15498378
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gastric remnant carcinoma: just another proximal gastric cancer or a unique entity?
    Newman E; Brennan MF; Hochwald SN; Harrison LE; Karpeh MS
    Am J Surg; 1997 Apr; 173(4):292-7. PubMed ID: 9136783
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The relationship between improved prognosis in gastric cancer patients in the last 25 years and changing methods of surgical and combined treatment.
    Popiela T; Kulig J; Kołodziejczyk P;
    Przegl Lek; 2000; 57 Suppl 5():9-13. PubMed ID: 11202309
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Surgical outcome of 483 patients with early gastric cancer: prognosis, postoperative morbidity and mortality, and gastric remnant cancer.
    Onodera H; Tokunaga A; Yoshiyuki T; Kiyama T; Kato S; Matsukura N; Masuda G; Tajiri T
    Hepatogastroenterology; 2004; 51(55):82-5. PubMed ID: 15011835
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Early gastric cancer in the remnant stomach.
    Takeda J; Toyonaga A; Koufuji K; Kodama I; Aoyagi K; Yano S; Ohta J; Shirozu K
    Hepatogastroenterology; 1998; 45(23):1907-11. PubMed ID: 9840174
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Progression and prognosis of gastric stump cancer.
    Hu X; Tian DY; Cao L; Yu Y
    J Surg Oncol; 2009 Nov; 100(6):472-6. PubMed ID: 19697396
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of the prognostic factors for liver metastasis of gastric cancer after hepatic resection: a multi-institutional study of the indications for resection.
    Shirabe K; Shimada M; Matsumata T; Higashi H; Yakeishi Y; Wakiyama S; Ikeda Y; Ezaki T; Fukuzawa S; Takenaka K; Kishikawa K; Ikeda T; Taguchi K; Maehara Y; Sugimachi K
    Hepatogastroenterology; 2003; 50(53):1560-3. PubMed ID: 14571786
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinicopathologic prognostic factors in patients with Borrmann type 4 gastric cancer: univariate and multivariate analyses.
    Yokota T; Kunii Y; Saito T; Teshima S; Narushima Y; Yamada Y; Iwamoto K; Kagami M; Takahashi M; Kikuchi S; Yamauchi H
    Ups J Med Sci; 2000; 105(3):227-34. PubMed ID: 11261608
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Indications for pancreaticosplenectomy in advanced gastric cancer.
    Chikara K; Hiroshi S; Masato N; Hirotoshi A; Goro M; Hidetaka O
    Hepatogastroenterology; 2001; 48(39):908-12. PubMed ID: 11462954
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinicopathologic characteristics and surgical outcomes of mucinous gastric carcinoma.
    Kunisaki C; Akiyama H; Nomura M; Matsuda G; Otsuka Y; Ono HA; Shimada H
    Ann Surg Oncol; 2006 Jun; 13(6):836-42. PubMed ID: 16604474
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Outcome in relation to numbers of nodes harvested in lymph node-positive gastric cancer.
    Deng JY; Liang H; Sun D; Pan Y; Zhang RP; Wang BG; Zhan HJ
    Eur J Surg Oncol; 2009 Aug; 35(8):814-9. PubMed ID: 19111430
    [TBL] [Abstract][Full Text] [Related]  

  • 20. T4 gastric carcinoma: the benefit of non-curative resection.
    Kim DY; Joo JK; Seo KW; Park YK; Ryu SY; Kim HR; Kim YJ; Kim SK
    ANZ J Surg; 2006 Jun; 76(6):453-7. PubMed ID: 16768767
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.